DK0710111T3 - Hormonalt middel til behandling af acne og dets anvendelse - Google Patents

Hormonalt middel til behandling af acne og dets anvendelse

Info

Publication number: DK0710111T3
Authority: DK; Denmark
Prior art keywords: hormonal; hormone; daily units; component; hormone component
Prior art date: 1993-07-01

Application number

DK94916880T

Other languages

English (en)

Inventor

Marika Dr Med Ehrlich

Herbert Prof Dr Kuhl

Original Assignee

Marika Dr Med Ehrlich

Herbert Prof Dr Kuhl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-01

Filing date

1994-06-03

Publication date

2001-12-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0710111(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-06-03 Application filed by Marika Dr Med Ehrlich, Herbert Prof Dr Kuhl filed Critical Marika Dr Med Ehrlich

2001-12-10 Application granted granted Critical

2001-12-10 Publication of DK0710111T3 publication Critical patent/DK0710111T3/da

Links

229940125697 hormonal agent Drugs 0.000 title abstract 3
208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
206010000496 acne Diseases 0.000 title abstract 2
239000005556 hormone Substances 0.000 abstract 5
229940088597 hormone Drugs 0.000 abstract 5
230000003054 hormonal effect Effects 0.000 abstract 4
239000000262 estrogen Substances 0.000 abstract 2
238000004806 packaging method and process Methods 0.000 abstract 2
101600111816 Homo sapiens Sex hormone-binding globulin (isoform 1) Proteins 0.000 abstract 1
102300044179 Sex hormone-binding globulin isoform 1 Human genes 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
230000002280 anti-androgenic effect Effects 0.000 abstract 1
239000000051 antiandrogen Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Physical Or Chemical Processes And Apparatus (AREA)
Materials For Medical Uses (AREA)

DK94916880T 1993-07-01 1994-06-03 Hormonalt middel til behandling af acne og dets anvendelse DK0710111T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4321957A DE4321957C2 (de)	1993-07-01	1993-07-01	Verwendung eines hormonalen Mittels zur Therapie der Akne
PCT/DE1994/000629 WO1995001180A1 (de)	1993-07-01	1994-06-03	Hormonales mittel zur therapie der akne und dessen verwendung

Publications (1)

Publication Number	Publication Date
DK0710111T3 true DK0710111T3 (da)	2001-12-10

Family

ID=6491735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94916880T DK0710111T3 (da)	1993-07-01	1994-06-03	Hormonalt middel til behandling af acne og dets anvendelse

Country Status (14)

Country	Link
EP (1)	EP0710111B1 (da)
JP (1)	JPH09500112A (da)
AT (1)	ATE205716T1 (da)
AU (1)	AU695894B2 (da)
BR (1)	BR9407340A (da)
CA (1)	CA2166121A1 (da)
DE (2)	DE4321957C2 (da)
DK (1)	DK0710111T3 (da)
ES (1)	ES2164103T3 (da)
HU (1)	HUT73234A (da)
NO (1)	NO308586B1 (da)
PT (1)	PT710111E (da)
UA (1)	UA43337C2 (da)
WO (1)	WO1995001180A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19534209A1 (de) *	1995-09-15	1997-03-20	Jenapharm Gmbh	Hormonales Mittel zur Behandlung der Haut
WO1999033856A1 (fr) *	1997-12-26	1999-07-08	Mochida Pharmaceutical Co., Ltd.	Inhibiteur de neoformation de vaisseaux sanguins contenant du dienogest en tant que principe actif
DE102004026679A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Darreichungsform zur hormonalen Kontrazeption
DE102004026670A1 (de) *	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102006003508A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Arzneimittel umfassend eine Hormonkombination
DE102006003509A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Kontrazeptivum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU565915B2 (en) *	1982-12-31	1987-10-01	Mortimer, C.H.	Pharmaceutical composition of antibiotic and anti- androgen
DE3442857A1 (de) *	1984-11-22	1986-05-22	Schering AG, 1000 Berlin und 4709 Bergkamen	Mittel zur behandlung von androgenisierungserscheinungen bei der frau
DE3916112A1 (de) *	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
DE4104385C1 (da) *	1991-02-09	1992-08-13	Marika Dr.Med. 6509 Framersheim De Ehrlich

1993
- 1993-07-01 DE DE4321957A patent/DE4321957C2/de not_active Expired - Lifetime
1994
- 1994-06-03 DK DK94916880T patent/DK0710111T3/da active
- 1994-06-03 DE DE59409869T patent/DE59409869D1/de not_active Expired - Fee Related
- 1994-06-03 UA UA95125308A patent/UA43337C2/uk unknown
- 1994-06-03 BR BR9407340A patent/BR9407340A/pt not_active Application Discontinuation
- 1994-06-03 ES ES94916880T patent/ES2164103T3/es not_active Expired - Lifetime
- 1994-06-03 EP EP94916880A patent/EP0710111B1/de not_active Expired - Lifetime
- 1994-06-03 PT PT94916880T patent/PT710111E/pt unknown
- 1994-06-03 WO PCT/DE1994/000629 patent/WO1995001180A1/de not_active Ceased
- 1994-06-03 AT AT94916880T patent/ATE205716T1/de not_active IP Right Cessation
- 1994-06-03 HU HU9503770A patent/HUT73234A/hu unknown
- 1994-06-03 AU AU68408/94A patent/AU695894B2/en not_active Ceased
- 1994-06-03 CA CA002166121A patent/CA2166121A1/en not_active Abandoned
- 1994-06-03 JP JP7503202A patent/JPH09500112A/ja active Pending
1995
- 1995-12-29 NO NO955347A patent/NO308586B1/no unknown

Also Published As

Publication number	Publication date
ATE205716T1 (de)	2001-10-15
JPH09500112A (ja)	1997-01-07
HUT73234A (en)	1996-07-29
UA43337C2 (uk)	2001-12-17
DE4321957C2 (de)	1995-09-28
EP0710111B1 (de)	2001-09-19
DE59409869D1 (de)	2001-10-25
NO955347D0 (no)	1995-12-29
PT710111E (pt)	2002-02-28
NO955347L (no)	1995-12-29
BR9407340A (pt)	1996-10-08
AU695894B2 (en)	1998-08-27
NO308586B1 (no)	2000-10-02
HU9503770D0 (en)	1996-02-28
CA2166121A1 (en)	1995-01-12
DE4321957A1 (de)	1995-01-12
AU6840894A (en)	1995-01-24
EP0710111A1 (de)	1996-05-08
WO1995001180A1 (de)	1995-01-12
ES2164103T3 (es)	2002-02-16

Similar Documents

Publication	Publication Date	Title
AU1255002A (en)	2002-05-21	Delayed-release pharmaceutical formulations
DE69432752D1 (de)	2003-07-03	Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
ATE296612T1 (de)	2005-06-15	Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
AR010385A1 (es)	2000-06-07	Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
PL315114A1 (en)	1996-10-14	Compounds exhibiting properties of releasing growth hormones
HUP0100801A2 (hu)	2001-08-28	Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására
NO963447L (no)	1996-08-19	Transdermale, terapeutiske systemer som inneholder seksualsteroider
DE69101080D1 (de)	1994-03-10	Diätfaser, Verfahren und physiologische aktive Zusammensetzung, die diese als aktives Ingredient enhält.
DE69827149D1 (de)	2004-11-25	Agmatin für die behandlung neuropathischer schmerzen
MY106938A (en)	1995-08-30	Method of treating premature ejaculation using sertraline
BR9406893A (pt)	1996-09-10	Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
ATE171873T1 (de)	1998-10-15	Antiglucocorticoidsteroide zur behandlung von angststörungen
DK0663835T3 (da)	1997-09-01	Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
DK0710111T3 (da)	2001-12-10	Hormonalt middel til behandling af acne og dets anvendelse
ES2139081T3 (es)	2000-02-01	Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
ATE237331T1 (de)	2003-05-15	Deuterierte wirkstoffe in transdermaler applikation
ZA923935B (en)	1993-02-24	New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
WO2001043705A3 (en)	2001-12-13	Compositions containing a retinoid and a stilbene for skin care
KR970705397A (ko)	1997-10-09	골다공증 치료를 위한 에스트로젠 화합물 및 부갑상선 호르몬(estrogens and parathyroid hormone for treating osteoporosis)
IT1269827B (it)	1997-04-15	Bicarbonato di lidocaina, suo uso farmaceutico e composizioni che lo contengono
GR1003059B (el)	1999-01-27	Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων
BG105441U (en)	2002-11-29	Composition of disinfectant solution and method for its preparation
MX9800697A (es)	1998-09-30	Uso de glicosidos de calendula para el tratamiento de psoriasis.
MX9709684A (es)	1998-06-28	Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.